Dual-tasking Effect on Gait in Children With Developmental Coordination Disorder
Launched by UNIVERSITY GHENT · May 1, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how children with Developmental Coordination Disorder (DCD) walk while doing two things at once, which is called "dual-tasking." The researchers want to understand how these tasks affect their walking patterns. The study is looking for children aged 7 to 17 who have been officially diagnosed with DCD, can walk for at least 15 minutes, and have good vision. Children with certain conditions, like neurological disorders or those who have had surgery on their legs, cannot participate.
During the study, participants will spend about three hours at the Gait Real-time Analysis Interactive Lab (GRAIL) at the university hospital of Ghent. They will take a motor test and walk on a treadmill at different speeds. The researchers will collect information about their walking movements and muscle activity, especially when the children are asked to think or move their arms while walking. This research could help improve our understanding of how children with DCD can manage walking when they have to do more than one task at a time.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • They have an official DCD diagnosis;
- • Are aged between 7 and 17 years old;
- • Can walk at least 15 minutes consecutively;
- • Have good or corrected vision.
- Exclusion Criteria:
- • They suffer from a neurological disorder;
- • Take medications that affect gait and balance;
- • Have undergone surgical procedures on the lower limbs in the past;
- • Experience pain in their lower limbs or back at the time of testing.
About University Ghent
University Ghent is a prestigious Belgian research institution renowned for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a multidisciplinary approach, the university fosters collaboration among leading experts in various fields, ensuring rigorous study design and ethical standards. University Ghent is dedicated to exploring new therapeutic modalities and enhancing healthcare outcomes, making significant contributions to both local and global health landscapes. Its state-of-the-art facilities and emphasis on research excellence position it as a pivotal sponsor in the realm of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ghent, , Belgium
Ghent, East Flanders, Belgium
Patients applied
Trial Officials
Lynn Bar-On
Principal Investigator
University Ghent
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported